HRES1595Referred to Committee

Expressing support for the designation of September 2026 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-10-01
Introduced
1
Cosponsors
HRES
ⓘ
Type

Sponsor

Emanuel Cleaver
Emanuel Cleaver
Democrat · MO · Representative
Votes with party: 98.9% (645 recorded votes)

Full profile: /officials/C001061

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-10-01

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

Plain-English summary pending. Introduced on 2026-10-01. Check back soon — summaries are generated as bills progress through Congress.

Subjects

Health

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 1595 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. RES. 1595 Expressing support for the designation of September 2026 as ``National Polycystic Kidney Disease Awareness Month'', and raising awareness and understanding of polycystic kidney disease. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 1, 2026 Mr. Cleaver (for himself and Mr. Graves) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Expressing support for the designation of September 2026 as ``National Polycystic Kidney Disease Awareness Month'', and raising awareness and understanding of polycystic kidney disease. Whereas designating September 2026 as ``National Polycystic Kidney Disease Awareness Month'' will raise public awareness and understanding of polycystic kidney disease, one of the most prevalent genetic kidney disorders, which affects approximately 500,000 people in the United States; Whereas National Polycystic Kidney Disease Awareness Month will help to foster an understanding of the impact polycystic kidney disease has on individuals and their families; Whereas polycystic kidney disease is a progressive, genetic disorder of the kidneys that causes damage to the kidneys and the cardiovascular, endocrine, hepatic, and gastrointestinal organ systems; Whereas polycystic kidney disease affects the health and finances of individuals, and equally affects individuals of all ages, races, ethnicities, and sexes; Whereas, of the individuals diagnosed with polycystic kidney disease, approximately 10 percent have no family history of the disease, with the disease developing as a spontaneous mutation; Whereas there are very few treatments and no cure for polycystic kidney disease, which is 1 of the 4 leading causes of kidney failure in the United States; Whereas almost 50 percent of individuals with polycystic kidney disease experience kidney failure by age 60; Whereas friends, loved ones, spouses, and caregivers of individuals with polycystic kidney disease can assist with the challenges created by polycystic kidney disease, including by helping such individuals maintain a healthy lifestyle and make regular visits to their health care providers; Whereas the severity of the symptoms of polycystic kidney disease and limited public awareness of the disease may cause individuals to forgo regular visits to their physicians or avoid following the health recommendations of their doctors, which experts suggest could help prevent further complications should kidney failure occur; Whereas individuals who have chronic, life-threatening diseases like polycystic kidney disease may experience depression; and Whereas the PKD Foundation and its more than 35,000 patient and family advocates around the United States are dedicated to-- (1) conducting research to find treatments and a cure for polycystic kidney disease; (2) fostering public awareness and understanding of polycystic kidney disease; (3) educating individuals and their families about the disease to improve their treatment and care; and (4) providing support, including by sponsoring the annual ``Walk for PKD'', to raise funds for polycystic kidney disease research, education, advocacy, and awareness: Now, therefore, be it Resolved, That the House of Representatives-- (1) expresses support for the designation of ``National Polycystic Kidney Disease Awareness Month''; (2) supports the goals and ideals of National Polycystic Kidney Disease Awareness Month to raise public awareness and understanding of polycystic kidney disease; (3) recognizes the need for additional research to find a cure for polycystic kidney disease; and (4) encourages all people in the United States and interested groups to support National Polycystic Kidney Awareness Month through appropriate ceremonies and activities to promote public awareness of polycystic kidney disease and to foster an understanding of the impact of the disease on individuals and their families. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.